124 related articles for article (PubMed ID: 1356806)
1. The interaction of R(+)- and S(-)-zacopride with PCPA to modify rodent aversive behaviour.
Barnes NM; Costall B; Ge J; Kelly ME; Naylor RJ
Eur J Pharmacol; 1992 Jul; 218(1):15-25. PubMed ID: 1356806
[TBL] [Abstract][Full Text] [Related]
2. Profiles of interaction of R(+)/S(-)-zacopride and anxiolytic agents in a mouse model.
Barnes NM; Cheng CH; Costall B; Ge J; Kelly ME; Naylor RJ
Eur J Pharmacol; 1992 Jul; 218(1):91-100. PubMed ID: 1356807
[TBL] [Abstract][Full Text] [Related]
3. Differential modulation of extracellular levels of 5-hydroxytryptamine in the rat frontal cortex by (R)- and (S)-zacopride.
Barnes NM; Cheng CH; Costall B; Ge J; Naylor RJ
Br J Pharmacol; 1992 Sep; 107(1):233-9. PubMed ID: 1384906
[TBL] [Abstract][Full Text] [Related]
4. The enantiomers of zacopride: an intra-species comparison of their potencies in functional and anxiolytic models.
Bill DJ; Coleman J; Hallett I; Middlefell VC; Rhodes KF; Fletcher A
Br J Pharmacol; 1995 Jul; 115(5):775-80. PubMed ID: 8548176
[TBL] [Abstract][Full Text] [Related]
5. Use of stereoisomers of zacopride to analyze actions of 5-hydroxytryptamine on enteric neurons.
Wade PR; Mawe GM; Branchek TA; Gershon MD
Am J Physiol; 1991 Jan; 260(1 Pt 1):G80-90. PubMed ID: 1987811
[TBL] [Abstract][Full Text] [Related]
6. The differential activities of R (+)- and S(-)-zacopride as 5-HT3 receptor antagonists.
Barnes JM; Barnes NM; Costall B; Domeney AM; Johnson DN; Kelly ME; Munson HR; Naylor RJ; Young R
Pharmacol Biochem Behav; 1990 Dec; 37(4):717-27. PubMed ID: 2128757
[TBL] [Abstract][Full Text] [Related]
7. Zacopride: anxiolytic profile in rodent and primate models of anxiety.
Costall B; Domeney AM; Gerrard PA; Kelly ME; Naylor RJ
J Pharm Pharmacol; 1988 Apr; 40(4):302-5. PubMed ID: 2900320
[TBL] [Abstract][Full Text] [Related]
8. Comparison of potencies of 5-HT3 receptor antagonists at inhibiting aversive behavior to illumination and the von Bezold-Jarisch reflex in the mouse.
Eglen RM; Lee CH; Khabbaz M; Fontana DJ; Daniels S; Kilfoil T; Wong EH
Neuropharmacology; 1994 Feb; 33(2):227-34. PubMed ID: 8035908
[TBL] [Abstract][Full Text] [Related]
9. Anxiolytic-like activity of R(+)- and S(-)-zacopride in mice.
Young R; Johnson DN
Eur J Pharmacol; 1991 Aug; 201(2-3):151-5. PubMed ID: 1686755
[TBL] [Abstract][Full Text] [Related]
10. 5-HT3 receptor agonism may be responsible for the emetic effects of zacopride in the ferret.
Middlefell VC; Price TL
Br J Pharmacol; 1991 May; 103(1):1011-2. PubMed ID: 1831684
[TBL] [Abstract][Full Text] [Related]
11. Zacopride and its optical isomers produce stereoselective antagonism of a 2-methylserotonin discriminative stimulus.
Young R; Glennon RA
Eur J Pharmacol; 1992 Feb; 212(1):117-9. PubMed ID: 1555633
[TBL] [Abstract][Full Text] [Related]
12. The influence of 5-HT2 and 5-HT4 receptor antagonists to modify drug induced disinhibitory effects in the mouse light/dark test.
Costall B; Naylor RJ
Br J Pharmacol; 1997 Nov; 122(6):1105-18. PubMed ID: 9401775
[TBL] [Abstract][Full Text] [Related]
13. Enhanced anxiolytic effect of zacopride enantiomers in diazepam-withdrawn rats.
File SE; Andrews N
Eur J Pharmacol; 1993 Jun; 237(1):127-30. PubMed ID: 8102974
[TBL] [Abstract][Full Text] [Related]
14. The (S)-isomer of [3H]zacopride labels 5-HT3 receptors with high affinity in rat brain.
Waeber C; Pinkus LM; Palacios JM
Eur J Pharmacol; 1990 Jun; 181(3):283-7. PubMed ID: 2384135
[TBL] [Abstract][Full Text] [Related]
15. The profiles of interaction of yohimbine with anxiolytic and putative anxiolytic agents to modify 5-HT release in the frontal cortex of freely-moving rats.
Cheng CH; Costall B; Ge J; Naylor RJ
Br J Pharmacol; 1993 Nov; 110(3):1079-84. PubMed ID: 7507776
[TBL] [Abstract][Full Text] [Related]
16. Agonist effects at putative central 5-HT4 receptors in rat hippocampus by R(+)- and S(-)-zacopride; no evidence for stereo-selectivity.
Boddeke HW; Kalkman HO
Neurosci Lett; 1992 Jan; 134(2):261-3. PubMed ID: 1589153
[TBL] [Abstract][Full Text] [Related]
17. 5-HT3 receptor antagonists block cocaine-induced locomotion via a PCPA-sensitive mechanism.
Svingos AL; Hitzemann R
Pharmacol Biochem Behav; 1992 Nov; 43(3):871-9. PubMed ID: 1448481
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the 5-HT3 receptor antagonist properties of ICS 205-930, GR38032F and zacopride.
Cohen ML; Bloomquist W; Gidda JS; Lacefield W
J Pharmacol Exp Ther; 1989 Jan; 248(1):197-201. PubMed ID: 2521513
[TBL] [Abstract][Full Text] [Related]
19. Zacopride, a potent 5-HT3 antagonist.
Smith WW; Sancilio LF; Owera-Atepo JB; Naylor RJ; Lambert L
J Pharm Pharmacol; 1988 Apr; 40(4):301-2. PubMed ID: 2900319
[TBL] [Abstract][Full Text] [Related]
20. Emetic activity of zacopride in ferrets and its antagonism by pharmacological agents.
Sancilio LF; Pinkus LM; Jackson CB; Munson HR
Eur J Pharmacol; 1990 Jun; 181(3):303-6. PubMed ID: 2384137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
